| Fund ID | 805-6493805501 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | No |
| 3(c)(7) exclusion | Yes |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| % of assets independently valued | 0% |
| Owned by the adviser or related persons | 1% |
| Owned by funds of funds | 27% |
| Owned by non-U.S. persons | 10% |
| Fund | Type | Gross assets |
|---|---|---|
| Andreessen Horowitz Lsv Fund III, L.P. | Venture Capital | $5.76B |
| Andreessen Horowitz Fund III, L.P. | Venture Capital | $5.11B |
| Cnk Fund IV, L.P. | Private Equity | $5.05B |
Ah Bio Fund I, L.P. reports $310 million in gross assets, among the top 23% of private funds by size.
Ah Bio Fund I, L.P. is managed by Ah Capital Management, L.L.C.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.